Elevated NF-κB signaling in Asherman syndrome patients and animal modelsXiangzhen Wang(First Affiliated Hospital of Jinan University), Xin Luo(First Affiliated Hospital of Jinan University)OncotargetJanuary 27, 201710.18632/oncotarget.14853Cited by 57SaveCiteExport RISWatch citationsRelated PapersInactivation of AKT, ERK and NF-κB by genistein derivative, 7-difluoromethoxyl-5,4′-di-n-octylygenistein, reduces ovarian carcinoma oncogenicity|Oncology Reports|2017|34